EAHP — European Association of Hospital Pharmacists

The European Association of Hospital Pharmacists (EAHP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education

	Webcast	Speakers
Keyote presentations	Keynote 1: Artificial Intelligence, to boldly go where no one has gone before	F. Rademakers
	Keynote 2 – Pharmacist prescribing – from vision to reality	R. Sharma
	Keynote 2 – Pharmacist prescribing – from vision to reality	S. Williams*
	Keynote 3 – Treated by computers? – a futuristic perspective of health care	K. Wac*
Student programme	Healthcare professionals’ collaboration as a key to patient-centred care	A. Tonna
Seminar CPS1	Combining centralised and bedside clinical pharmacy	I. Spriet
Seminar CPS1	Q&A	S. Antoniou
Seminar CPS2	The role of a hospital pharmacist in addressing health literacy	L. Sahm
Seminar CPS2	Q&A	M. Wolf*
Seminar CPS3	Antimicrobial resistance – did we lose the magic bullet?	U. Theuretzbacher
Seminar CPS3	Q&A	M. Fellhauer
Seminar CPS4	Good evening pharmacists! Case studies on antimicrobial resistance	I. Urtane
		J. Lass
	Q&A	A. von Ameln-Mayerhofer
Seminar ER1	Hospital pharmacy career – by design or left to chance?	H. Farinha
Seminar ER1	Q&A	S. Amann
Seminar IG1	What’s in the crystal ball? – the future of healthcare – HP get ready!	K. M. Pedersen
Seminar IG1	Q&A	L. Tzimis
Seminar IG2	The art of benchmarking	M. Cillis
Seminar IG2	Q&A	E. Estlander*
Seminar IG3	Hospital pharmacists facing new demands – transform your pharmacy team!	A. Weygand
		H. van Onzenoort
	Q&A	A. Hogg
Interactive session 1	The pros and cons of telepharmacy	E. Zygadlo-Kozaczuk
Interactive session 1	Q&A	K. McDonald*
Interactive session 2	Chemotherapy dose banding – development and implementation	R. Nuttall
Interactive session 2	Q&A	M. Rasschaert
Interactive session 3	Peri-operative pharmacy services and the enhanced recovery pathway	N. Bansal
Interactive session 3	Q&A	S. Poggio
Pharmacotherapy	Pharmacotherapy – COVID19 – Repurposed drugs and treatment	J. Neyts*
Pharmacotherapy		S. Pelzl
Seminar PC1	Relax – your 3D printer is doing your work for you	P. van Oirschot*
Seminar PC1	Q&A	T. Hoppe-Tichy*
Seminar PC2	GMP – more than a 3-letter word	K. Froidbise
Seminar PC2	Q&A	K. Schimmel
Seminar PSQ1	Involve patients in improving their care!	P. Barroso Inácio
Seminar PSQ1	Q&A	B. Dean Franklin
Seminar PSQ2	When Chatbots meet patients and can assist hospital pharmacists!	B. Brouard*
Seminar PSQ2	Q&A	B. Brouard*
Seminar PSQ3	Transfer of care – mind the gap	A. Gray
	Transfer of care – mind the gap	S. Daliri
	Q&A	I. Krämer
Seminar SPD1	New strategies to overcome drug shortages	H. Jenzer*
	New strategies to overcome drug shortages	S. Groesser*
	Q&A	P. Petrou
Seminar SPD2	Medicines for every disease – return on investment vs unmet clinical needs	W-D. Ludwig
Seminar SPD2	Q&A	J. Schildmann
Workshop 1	Design your own “Elevator Pitch” – speed dating for hospital pharmacists	J. Hayes
Workshop 2	Critical care multidisciplinary team – the role of the Hospital Pharmacist with a focus on the COVID-19 pandemic	G. Echarri
Workshop 2		I. Aquerreta
Workshop 3	Clinical prioritisation tools to improve patient care	P. Lewis
Workshop 3	Clinical prioritisation tools to improve patient care	S. Williams
Workshop 4	Pharmacists – to prescribe or not to prescribe, that is the question…	J. Bateman
Workshop 4		B. Morath
Workshop 5	Design your career here!	G. Fleming
Workshop 5	Design your career here!	S. Amman
Synergy	Oncology biosimilars – Hospital pharmacists making the difference (sponsored by an educational grant from Amgen)	A. Gouveia
		S. Simoens*
	Q&A – 23 March	I. Boukovinas*
Synergy	Oncology biosimilars – Hospital pharmacists making the difference (sponsored by an educational grant from Amgen)	A. Gouveia
		S. Simoens*
	Q&A – 27 March	I. Boukovinas*
Synergy	The Hospital Pharmacist’s role in antithrombotic stewardship (sponsored by an educational grant from Bayer) with Paul Wright	P. Wright*
Synergy	Q&A – 23 March	P. Wright*
Synergy	The Hospital Pharmacist’s role in antithrombotic stewardship (sponsored by an educational grant from Bayer) with Patricia van den Bemt	P. van den Bemt
Synergy	Q&A – 24 March	P. van den Bemt
Synergy	Live discussion with faculty: The Hospital Pharmacist’s role in antithrombotic stewardship (sponsored by an educational grant from Bayer) – 28 April	P. Wright*
Synergy		P. van den Bemt
Synergy	Biosimilars in colorectal cancer – what’s your gut feeling? (sponsored by an educational grant from Pfizer)	P. Cornes*
Synergy	Q&A – 24 March	T. Tesař
Synergy	Biosimilars in colorectal cancer – what’s your gut feeling? (sponsored by an educational grant from Pfizer)	P. Cornes*
Synergy	Q&A – 27 March	T. Tesař

Satellite symposia (not ACPE accredited): The information related to satellite symposia is provided to you by commercial companies, external to EAHP. EAHP makes no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to these presentations or the information, products, services, or related graphics contained in the presentations for any purpose. Any reliance you place on such information is therefore strictly at your own risk. In no event will EAHP be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the presentations.

Simplivia Healthcare	Handling Hazardous Drugs with Closed System Transfer Devices: From Exposure to Safety with Chemfort™	H. Dhillon
		S. Eisenberg
		P. Sessink
Fresenius Kabi	Biosimilars in clinical practice: do pharmacists and physicians agree? with Dr Monte and Dr Bourgon	E. Monte
		L. Bourgon
B.Braun Melsungen AG, Grifols	How Information Technologies and Robotics can improve Safety and Traceability during Chemotherapy Process	L. A. Goldberg
		E. Moreno
		M. Paulsson
		O. Delgado Sánchez

EAHP Forum

Conversations and groups